Roel Bogie

Chapter 3

Prevalence of LSTs Prevalence of patients with LSTs in neoplasm(s) Prevalence of LSTs of all neoplasms Location Endoscopic subtype Histology Males (%) Teixeira 1996 • • • • P Therapy (all) NA 2 NA NA syndrome LST term used Serrated lesions excluded Study design Duration of study (years) Age of the study population (years)

1 Mean 62 43.1%

Exclusion criteria

Inclusion criteria

Jaramillo 1995 • • º º P All indications FAP, IBD, Lynch

LST

definition

Prevalence estimates LST features

Table 3.1: (continuation)

Study

P: Prospective; R: Retrospective; All indications: screening, surveillance and symptoms; Therapy (all): EMR, ESD and surgery; IBD: inflammatory bowel disease; FAP: familial adenomatous coli syndrome; SPS: serrated polyposis syndrome; NA: not available; •: yes; º : no; *: Patients with polyps in general instead of LSTs.

48